SE501677C2 - Biologiskt aktiva vasopressinanaloger, farmaceutiska preparat innehållande dem samt deras användning för framställning av läkemedel - Google Patents

Biologiskt aktiva vasopressinanaloger, farmaceutiska preparat innehållande dem samt deras användning för framställning av läkemedel

Info

Publication number
SE501677C2
SE501677C2 SE9302124A SE9302124A SE501677C2 SE 501677 C2 SE501677 C2 SE 501677C2 SE 9302124 A SE9302124 A SE 9302124A SE 9302124 A SE9302124 A SE 9302124A SE 501677 C2 SE501677 C2 SE 501677C2
Authority
SE
Sweden
Prior art keywords
medicament
manufacture
vasopressin
vasopressin analogue
pct
Prior art date
Application number
SE9302124A
Other languages
English (en)
Swedish (sv)
Other versions
SE9302124D0 (sv
SE9302124L (sv
Inventor
Anders Nilsson
Haakan Olsson
Christina Soederberg-Ahlm
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Priority to SE9302124A priority Critical patent/SE501677C2/sv
Publication of SE9302124D0 publication Critical patent/SE9302124D0/xx
Priority to ZA944195A priority patent/ZA944195B/xx
Priority to IL11001894A priority patent/IL110018A0/xx
Priority to CZ953322A priority patent/CZ332295A3/cs
Priority to AU70883/94A priority patent/AU7088394A/en
Priority to KR1019950705293A priority patent/KR960702847A/ko
Priority to PCT/SE1994/000594 priority patent/WO1995000548A1/en
Priority to PL94312202A priority patent/PL312202A1/xx
Priority to FI956050A priority patent/FI956050A0/fi
Priority to US08/553,555 priority patent/US5698516A/en
Priority to EP94919935A priority patent/EP0703924A1/en
Priority to JP7502710A priority patent/JPH08511557A/ja
Priority to CN94192496A priority patent/CN1125451A/zh
Priority to CA002163352A priority patent/CA2163352A1/en
Priority to HU9503596A priority patent/HUT73674A/hu
Publication of SE9302124L publication Critical patent/SE9302124L/sv
Publication of SE501677C2 publication Critical patent/SE501677C2/sv
Priority to NO955058A priority patent/NO955058L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/16—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/15—Oxytocin or vasopressin; related peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
SE9302124A 1993-06-18 1993-06-18 Biologiskt aktiva vasopressinanaloger, farmaceutiska preparat innehållande dem samt deras användning för framställning av läkemedel SE501677C2 (sv)

Priority Applications (16)

Application Number Priority Date Filing Date Title
SE9302124A SE501677C2 (sv) 1993-06-18 1993-06-18 Biologiskt aktiva vasopressinanaloger, farmaceutiska preparat innehållande dem samt deras användning för framställning av läkemedel
ZA944195A ZA944195B (en) 1993-06-18 1994-06-14 Biologically active vasopressin analogues
IL11001894A IL110018A0 (en) 1993-06-18 1994-06-15 Biologically active vasopressin analogues
HU9503596A HUT73674A (en) 1993-06-18 1994-06-16 Biologically active vasopressin analogues
FI956050A FI956050A0 (fi) 1993-06-18 1994-06-16 Biologisesti aktiiviset vasopressiinianalogit
EP94919935A EP0703924A1 (en) 1993-06-18 1994-06-16 Biologically active vasopressin analogues
KR1019950705293A KR960702847A (ko) 1993-06-18 1994-06-16 생물학적 활성의 바소프레신 유사체
PCT/SE1994/000594 WO1995000548A1 (en) 1993-06-18 1994-06-16 Biologically active vasopressin analogues
PL94312202A PL312202A1 (en) 1993-06-18 1994-06-16 Biologically active vasopressin analogues
CZ953322A CZ332295A3 (en) 1993-06-18 1994-06-16 Biologically active analogs of vasopressin
US08/553,555 US5698516A (en) 1993-06-18 1994-06-16 Biologically active vasopressin analogues
AU70883/94A AU7088394A (en) 1993-06-18 1994-06-16 Biologically active vasopressin analogues
JP7502710A JPH08511557A (ja) 1993-06-18 1994-06-16 生物学的活性を有するバソプレッシン類似体
CN94192496A CN1125451A (zh) 1993-06-18 1994-06-16 生物活性加压素类似物
CA002163352A CA2163352A1 (en) 1993-06-18 1994-06-16 Biologically active vasopressin analogues
NO955058A NO955058L (no) 1993-06-18 1995-12-13 Biologiske aktive vasopressinanaloger

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9302124A SE501677C2 (sv) 1993-06-18 1993-06-18 Biologiskt aktiva vasopressinanaloger, farmaceutiska preparat innehållande dem samt deras användning för framställning av läkemedel

Publications (3)

Publication Number Publication Date
SE9302124D0 SE9302124D0 (sv) 1993-06-18
SE9302124L SE9302124L (sv) 1994-12-19
SE501677C2 true SE501677C2 (sv) 1995-04-10

Family

ID=20390346

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9302124A SE501677C2 (sv) 1993-06-18 1993-06-18 Biologiskt aktiva vasopressinanaloger, farmaceutiska preparat innehållande dem samt deras användning för framställning av läkemedel

Country Status (16)

Country Link
US (1) US5698516A (ja)
EP (1) EP0703924A1 (ja)
JP (1) JPH08511557A (ja)
KR (1) KR960702847A (ja)
CN (1) CN1125451A (ja)
AU (1) AU7088394A (ja)
CA (1) CA2163352A1 (ja)
CZ (1) CZ332295A3 (ja)
FI (1) FI956050A0 (ja)
HU (1) HUT73674A (ja)
IL (1) IL110018A0 (ja)
NO (1) NO955058L (ja)
PL (1) PL312202A1 (ja)
SE (1) SE501677C2 (ja)
WO (1) WO1995000548A1 (ja)
ZA (1) ZA944195B (ja)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE501678C2 (sv) * 1993-07-13 1995-04-10 Ferring Bv Peptid med oxytocinantagonistaktivitet samt farmaceutisk komposition innehållande nämnda peptid
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
PT1530967E (pt) * 2003-11-13 2006-09-29 Ferring Bv Embalagem blister e uma forma de dosagem solida que compreende desmopressina.
SE528446C2 (sv) * 2006-03-02 2006-11-14 Ferring Int Ct Sa Farmaceutisk sammansättning innefattande desmopressin, kiseldioxid och stärkelse
RU2342949C1 (ru) * 2007-03-26 2009-01-10 Юрий Георгиевич Жуковский Применение [дезамино-1, изолейцин-3, аргинин-8]вазопрессина в качестве средства для увеличения выведения почкой солей натрия и усиления обратного избирательного всасывания из почечных канальцев в кровь воды-растворителя
US8399410B2 (en) 2007-08-06 2013-03-19 Allergan, Inc. Methods and devices for desmopressin drug delivery
DK3085381T3 (en) 2008-05-21 2018-05-28 Ferring Bv ORODISPERSIBLE DESMOPRESSIN TO INCREASE THE INITIAL PERIOD OF SLEEP UNDERSTANDED BY NEW TURRY
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
JO3371B1 (ar) * 2013-07-26 2019-03-13 Ferring Bv ناهضات مستقبل فاسوبريسين 2
US9687526B2 (en) 2015-01-30 2017-06-27 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9744209B2 (en) 2015-01-30 2017-08-29 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9750785B2 (en) 2015-01-30 2017-09-05 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9937223B2 (en) 2015-01-30 2018-04-10 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9925233B2 (en) 2015-01-30 2018-03-27 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
US9375478B1 (en) 2015-01-30 2016-06-28 Par Pharmaceutical, Inc. Vasopressin formulations for use in treatment of hypotension
RU2634272C1 (ru) * 2016-08-10 2017-10-24 Закрытое акционерное общество "Санкт-Петербургский институт фармации" Композиция с дезамино-аргинин-вазотоцином для парентерального введения и способ её получения

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE399252B (sv) * 1976-05-24 1978-02-06 Ferring Ab Forfarande for framstellnign av antidiuretiskt verkande desamino-asparagin Ÿ4-d-argininŸ8-vasopressin
CA1246055A (en) * 1980-03-24 1988-12-06 Joseph H. Cort N-.omega.-substituted hormonogens of vasopressin and its synthetic analogs
US4491577A (en) * 1981-11-16 1985-01-01 The Medical College Of Ohio Antagonists of the antidiuretic action of arginine vasopressin

Also Published As

Publication number Publication date
WO1995000548A1 (en) 1995-01-05
CZ332295A3 (en) 1996-06-12
US5698516A (en) 1997-12-16
HU9503596D0 (en) 1996-02-28
FI956050L (fi) 1995-12-15
KR960702847A (ko) 1996-05-23
CA2163352A1 (en) 1995-01-05
NO955058D0 (no) 1995-12-13
HUT73674A (en) 1996-09-30
NO955058L (no) 1995-12-13
FI956050A7 (fi) 1995-12-15
EP0703924A1 (en) 1996-04-03
AU7088394A (en) 1995-01-17
FI956050A0 (fi) 1995-12-15
CN1125451A (zh) 1996-06-26
SE9302124D0 (sv) 1993-06-18
JPH08511557A (ja) 1996-12-03
PL312202A1 (en) 1996-04-01
IL110018A0 (en) 1994-10-07
ZA944195B (en) 1995-02-08
SE9302124L (sv) 1994-12-19

Similar Documents

Publication Publication Date Title
US4024248A (en) Peptides having LH-RH/FSH-RH activity
SE501677C2 (sv) Biologiskt aktiva vasopressinanaloger, farmaceutiska preparat innehållande dem samt deras användning för framställning av läkemedel
US6143722A (en) Heptapeptide oxytocin analogues
FI77047C (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara peptider, vilka aer antagonister av antidiuretisk verkan hos det antidiuretiska hormonet.
FI71567C (fi) Foerfarande foer framstaellning av gonadoliberinderivat.
EP2377579A1 (en) Cyclic peptide CXCR4 antagonists
JPS63154699A (ja) バソプレシン拮抗剤
HU199879B (en) Process for producing hexapeptides and pharmaceutical compositions comprising same as active ingredient
US4481194A (en) Des-proline-des-glycine vasopressin antagonists
US4481193A (en) Des-proline vasopressin antagonists
NO854645L (no) Fremgangsmaate for fremstilling av basiske cykliske peptider.
CA1249399A (en) Process for preparing v.sub.1-vasopressin antagonists
CA2405704C (en) Bombesin analogs for treatment of cancer
JPS6094997A (ja) 塩基性ヘプタペプチド・バソプレシン拮抗物質
US4876243A (en) Vasopressin compounds
AU676071B2 (en) Peptides exhibiting oxytocin antagonistic activity
Manning et al. Potent V2/V1a vasopressin antagonists with C-terminal ethylenediamine-linked retro-amino acids
NO862406L (no) Vasopressin-antagonister.
EP0380554B1 (en) Vasoactive peptides
CA2405724C (en) Substance p analogs for the treatment of cancer
AU595506B2 (en) Aromatic basic-tailed vasopressin antagonists
CA1249397A (en) Process for preparing des-proline vasopressin antagonists
EP0234935A2 (en) Vasopressin compounds
CA2385910A1 (en) Somatostatin analogs for the treatment of cancer
JP2714425B2 (ja) ポリペプチド

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 9302124-4

Format of ref document f/p: F